Breaking News Instant updates and real-time market news.

CVNA

Carvana

$49.92 /

+14.11 (+39.40%)

, ALLY

Ally Financial

$13.91 /

+1.64 (+13.37%)

15:35
03/24/20
03/24
15:35
03/24/20
15:35

Ally Financial doubles Carvana loan purchase program to $2B

Carvana (CVNA) announced an increase and extension of its current loan purchase program with Ally Financial (ALLY), which the company said highlights "the deep relationship that has been built between the two companies over the past six years." Ally will provide up to $2.0B of capacity for the purchase of finance receivables over the next 12 months and broaden the set of customers covered by the agreement. "This commitment from Ally puts Carvana in a strong position to provide our customers fair, simple financing in this time when so many need it," said Ernie Garcia, Carvana founder and CEO. "As we work through the current business challenges facing the auto industry, the Ally team remains unwavering in its focus on finding the best solutions to help our dealer customers," said Doug Timmerman, president of Auto Finance for Ally. "We're pleased to have the expertise and agility to deliver a financing agreement that supports Carvana's innovative, digital consumer experience."

CVNA

Carvana

$49.92 /

+14.11 (+39.40%)

ALLY

Ally Financial

$13.91 /

+1.64 (+13.37%)

  • 21

    Apr

CVNA Carvana
$49.92 /

+14.11 (+39.40%)

03/24/20 JPMorgan
Carvana price target lowered to $45 from $55 at JPMorgan
03/23/20 Wells Fargo
Carvana price target lowered to $50 from $110 at Wells Fargo
02/27/20 Craig-Hallum
Carvana price target raised to $55 from $40 at Craig-Hallum
02/27/20 Deutsche Bank
Carvana price target lowered to $105 from $120 at Deutsche Bank
ALLY Ally Financial
$13.91 /

+1.64 (+13.37%)

02/20/20
Fly Intel: Top five analyst downgrades
02/20/20
Fly Intel: Top five analyst upgrades
02/20/20 Nomura Instinet
Nomura upgrades Ally Financial to Buy, sees opportunity in selloff
02/20/20 Nomura Instinet
Ally Financial upgraded to Buy from Neutral at Nomura Instinet

TODAY'S FREE FLY STORIES

Hot Stocks
Boeing extends Seattle production suspension due to COVID-19 » 18:10
04/05/20
04/05
18:10
04/05/20
18:10
BA

Boeing

$124.59 /

+1.38 (+1.12%)

Boeing announced that it…

Boeing announced that it is extending the temporary suspension of production operations at all Puget Sound area and Moses Lake sites until further notice. "These actions are being taken in light of the company's continuing focus on the health and safety of employees, current assessment of the spread of COVID-19 in Washington state, the reliability of the supply chain and additional recommendations from government health authorities," the plane maker said in a statement Sunday night. During the suspension, Boeing said it will continue to implement additional health and safety measures at its facilities to protect employees. These measures include new visual cues to encourage physical distancing, more frequent and thorough cleaning of work and common areas and staggering shift times to reduce the flow of employees arriving and departing work, among many other improvements. It added, "As the suspension of operations continues, Boeing will monitor government guidance and actions on COVID-19 and associated impact on all company operations. Boeing sites that remain open are being monitored and assessed on a daily basis."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
3M responds to reporting on alleged seizure of N95 respirator shipments » 17:30
04/05/20
04/05
17:30
04/05/20
17:30
MMM

3M

$133.90 /

-3.96 (-2.87%)

3M issued the following…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
GM offers blueprint for face masks to auto parts suppliers, CNBC reports » 17:23
04/05/20
04/05
17:23
04/05/20
17:23
GM

General Motors

$18.03 /

-0.15 (-0.83%)

General Motors is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Livent upgraded to Market Perform from Underperform at BMO Capital » 16:17
04/05/20
04/05
16:17
04/05/20
16:17
LTHM

Livent

$4.73 /

+0.125 (+2.71%)

, ALB

Albemarle

$52.72 /

-0.92 (-1.72%)

, SQM

SQM

$21.07 /

-0.96 (-4.36%)

BMO Capital analyst Joel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Amazon, test makers in contact for potential employees' screenings, Reuters says » 15:52
04/05/20
04/05
15:52
04/05/20
15:52
AMZN

Amazon.com

$1,905.33 /

-11.69 (-0.61%)

, ABT

Abbott

$79.50 /

+0.075 (+0.09%)

, TMO

Thermo Fisher

$281.84 /

-5.125 (-1.79%)

Amazon (AMZN) has been in…

Amazon (AMZN) has been in contact with the CEOs of two coronavirus test makers as it considers how to screen its staff and reduce the risk of infection at its warehouses, Reuters' Jeffrey Dastin and Krystal Hu report, citing internal meeting notes. The chief executives of Abbott Laboratories (ABT) and Thermo Fisher Scientific (TMO) have told Amazon they would like to work with the e-commerce company, though the U.S. government is taking up all of their testing capacity at present, the notes said. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Capital One not using CFTC waiver related to oil lending, Reuters says » 15:28
04/05/20
04/05
15:28
04/05/20
15:28
COF

Capital One

$42.27 /

-1.72 (-3.91%)

Capital One said it would…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Zoom CEO tells WSJ 'I really messed up' on security » 15:26
04/05/20
04/05
15:26
04/05/20
15:26
ZM

Zoom Video

$128.08 /

+6.24 (+5.12%)

In the space of a month,…

In the space of a month, Zoom's videoconferencing business Eric Yuan founded nine years ago has gone from an enterprise-software provider little known outside the business world to a near-ubiquitous social lifeline for homebound Americans and, most recently, the subject of complaints about privacy problems and harassment on its platform, The Wall Street Journal's Aaron Tilley and Robert McMillan report. The whiplash has left Yuan trying to appease upset users and figure out what went wrong-and rethinking a company culture that for nearly a decade was focused on ease of use. "'If we mess up again, it's done,' I thought a lot last night," he told The Wall Street Journal in an interview Friday. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Trump threatens tariffs on oil imports to 'protect' energy workers, Reuters says » 15:18
04/05/20
04/05
15:18
04/05/20
15:18
BP

BP

$24.72 /

-1.32 (-5.07%)

, COP

ConocoPhillips

$32.90 /

-0.945 (-2.79%)

, TOT

Total

$35.76 /

-3.85 (-9.72%)

, XOM

Exxon Mobil

$39.20 /

-1.19 (-2.95%)

, CVX

Chevron

$75.15 /

-1.07 (-1.40%)

, RDS.A

Royal Dutch Shell

$36.24 /

-2.78 (-7.12%)

President Donald Trump…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Gilead to donate experimental COVID-19 drug Remdesivir » 15:13
04/05/20
04/05
15:13
04/05/20
15:13
GILD

Gilead

$78.22 /

+1.255 (+1.63%)

Gilead Sciences said it…

Gilead Sciences said it is donating 1.5M doses of its experimental anti-coronavirus drug remdesivir, which could treat 140,000 patients. In an open letter, Chairman and CEO Daniel O'Day said that the drug will be offered for compassionate use, expanded access and clinical trials, and will treat patients with severe symptoms. "In addition to the expanded access programs, we continue to provide remdesivir on an individual compassionate use basis for children and pregnant women. More than 1,700 patients have now been treated through these programs. [...] As soon as we knew that remdesivir may have potential in treating the novel coronavirus, our teams began to establish a supply chain for large-scale production. Then, as now, there were many unknowns including how long the outbreak would last, at what scale and whether remdesivir is a safe and effective treatment for COVID-19. We made the decision to invest and scale up regardless, because if remdesivir was going to be needed for patients, we had to be ready. In the space of two months, we have significantly increased our available supply of remdesivir using the inventory of active pharmaceutical ingredients we already had on hand. Our existing supply, including finished product ready for distribution as well as investigational medicine in the final stages of production, amounts to 1.5 million individual doses. Depending on the optimal duration of treatment, which is something we are studying in clinical trials, this supply could equate to well over 140,000 treatment courses for patients.[...] Gilead is providing the entirety of this existing supply at no cost, to treat patients with the most severe symptoms of COVID-19. The 1.5 million individual doses are available for compassionate use, expanded access and clinical trials and will be donated for broader distribution following any potential future regulatory authorizations. These doses are for treating patients with severe symptoms, through daily intravenous infusions in a hospital setting. Having a potential treatment in our hands comes with significant responsibility. Providing our existing supplies at no charge is the right thing to do, to facilitate access to patients as quickly as possible and in recognition of the public emergency posed by this pandemic." Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Luckin Coffee business to continue amid financial fraud probe, Reuters reports » 14:56
04/05/20
04/05
14:56
04/05/20
14:56
LK

Luckin Coffee

$5.37 /

-0.98 (-15.43%)

, SBUX

Starbucks

$63.09 /

-1.89 (-2.91%)

Luckin Coffee (LK) said…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Gaps in Amazon COVID-19 response fuel warehouse workers demands, NYTimes says » 14:51
04/05/20
04/05
14:51
04/05/20
14:51
AMZN

Amazon.com

$1,905.33 /

-11.69 (-0.61%)

As millions of Americans…

As millions of Americans heed government orders to hunker down, ordering food and medicines and books and puzzle boards for home delivery, many of Amazon's 400,000 warehouse workers have stayed on the job, fulfilling the crushing demands of a country suddenly working and learning from home, The New York Times' Karen Weise and Kate Conger report. For all of its high-tech sophistication, Amazon's vast e-commerce business is dependent on an army of workers operating in warehouses they now fear are contaminated with the coronavirus, the authors note. While Amazon's workers are not unionized, the crisis has given workplace organizers unexpected leverage to demand better pay, better sick leave and more of a voice in how the company is run. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
PAVmed to host business news update conference call » 14:49
04/05/20
04/05
14:49
04/05/20
14:49
PAVM

PAVmed

$1.79 /

-0.09 (-4.79%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
Conference/Events
U.S. Gold to hold investor update webcast » 14:46
04/05/20
04/05
14:46
04/05/20
14:46
USAU

U.S. Gold

$4.95 /

+0.19 (+3.99%)

President & CEO Karr…

President & CEO Karr provides an update and outlook for the Company on a webcast to be held on April 7 at 11:30 am. Webcast Link

Periodicals
Big tobacco joining race for COVID-19 vaccine, WSJ reports » 14:38
04/05/20
04/05
14:38
04/05/20
14:38
BTI

British American Tobacco

$36.22 /

-0.69 (-1.87%)

, PM

Philip Morris

$73.42 /

-0.88 (-1.18%)

Lucky Strike owner…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Gilead accelerating production of experimental COVID-19 drug, WSJ reports » 14:35
04/05/20
04/05
14:35
04/05/20
14:35
GILD

Gilead

$78.22 /

+1.255 (+1.63%)

Gilead Sciences has…

Gilead Sciences has ramped up production of its experimental coronavirus drug, The Wall Street Journal's Anna Wilde Mathews and Jonathan Rockoff report. The drugmaker said it now has 1.5M individual doses of its drug remdesivir on hand, an amount that could be enough to supply more than 140,000 patients. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
United cuts NY flights as city hunkers down, WSJ reports » 14:32
04/05/20
04/05
14:32
04/05/20
14:32
UAL

United Airlines

$22.89 /

-0.53 (-2.26%)

United Airlines is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Incyte to host conference call » 14:16
04/05/20
04/05
14:16
04/05/20
14:16
INCY

Incyte

$78.68 /

+1.67 (+2.17%)

Conference call to…

Conference call to discuss data from the Phase 3 TRuE-AD Trials of Ruxolitinib Cream in Atopic Dermatitis will be held on April 6 at 8 am. Webcast Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
X4 Pharmaceuticals to hold virtual analyst webinar » 14:09
04/05/20
04/05
14:09
04/05/20
14:09
XFOR

X4 Pharmaceuticals

$8.98 /

+0.13 (+1.47%)

Virtual Analyst Webinar:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
U.S. banks to defend dividend payments as pandemic crisis continues, FT reports » 14:08
04/05/20
04/05
14:08
04/05/20
14:08
BAC

Bank of America

$20.03 /

-0.535 (-2.60%)

, C

Citi

$37.48 /

-1.82 (-4.63%)

, JPM

JPMorgan

$84.08 /

-1.57 (-1.83%)

, USB

U.S. Bancorp

$31.21 /

-1.5 (-4.59%)

, WFC

Wells Fargo

$26.23 /

-0.98 (-3.60%)

, GS

Goldman Sachs

$147.07 /

-2.87 (-1.91%)

, MS

Morgan Stanley

$33.85 /

-0.045 (-0.13%)

America's biggest…

America's biggest banks will defend their plans to continue paying dividends in submissions to regulators on Monday, just days after Europe's regulators urged lenders to abandon shareholder payouts while they dealt with the coronavirus pandemic, Financial Times' Laura Noonan reports. U.S. banks' annual capital plans, due to be submitted to the Federal Reserve on Monday, are expected to include proposals to continue paying dividends, reinforcing comments from prominent bank chief executives in recent days, according to people familiar with the matter. Publicly traded companies in the space include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC).Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Intuit launches free Stimulus Registration product » 14:02
04/05/20
04/05
14:02
04/05/20
14:02
INTU

Intuit

$218.12 /

-7.19 (-3.19%)

TurboTax launched a free,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Great Ajax announces $80M private placement » 13:57
04/05/20
04/05
13:57
04/05/20
13:57
AJX

Great Ajax

$4.47 /

+0.06 (+1.36%)

Great Ajax announced that…

Great Ajax announced that the company has entered into a securities purchase agreement pursuant to which it has agreed to issue and sell $80M of the company's preferred stock and warrants to affiliates of an institutional accredited investor in a private placement. The company will issue 1,200,000 shares of the company's 7.25% Series A Fixed-to-Floating Rate Preferred Stock, liquidation preference $25 per share, and 2,000,000 shares of the company's 5.00% Series B Fixed-to-Floating Rate Preferred Stock, liquidation preference $25 per share, each at a purchase price per share of $25 and two series of five-year warrants to purchase an aggregate of 4,000,000 shares of the company's common stock at an exercise price of $10 per share. Each series of warrants includes a put option that will allow the holder to sell the warrants to the company at a specified put price on or after July 6, 2023. In addition, the company has granted the investor an option to purchase up to an additional 300,000 shares of the company's Series A Preferred Stock, 500,000 shares of the company's Series B Preferred Stock and warrants to purchase an aggregate of 1,000,000 shares of the company's common stock on the same terms. The company expects to use the net proceeds from the private placement to acquire mortgage loans and mortgage-related assets consistent with the company's investment strategy.

Conference/Events
MGM Resorts participates in a conference call with JPMorgan » 13:51
04/05/20
04/05
13:51
04/05/20
13:51
MGM

MGM Resorts

$10.57 /

-0.94 (-8.17%)

Gaming & Lodging…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
United Therapeutics participates in a conference with JPMorgan » 13:44
04/05/20
04/05
13:44
04/05/20
13:44
UTHR

United Therapeutics

$92.58 /

-0.83 (-0.89%)

Biotechnology Analyst Fye…

Biotechnology Analyst Fye holds a conference call with CEO Hornbuckler and CFO Sanders on April 7 at 1 pm hosted by JPMorgan.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
JPMorgan LatAm utilities analysts to hold an analyst/industry conference call » 13:37
04/05/20
04/05
13:37
04/05/20
13:37

LatAm Utilities Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
JPMorgan retail analysts to hold an analyst/industry conference call » 13:33
04/05/20
04/05
13:33
04/05/20
13:33

Retail/Hardlines &…

Retail/Hardlines & Broadlines Analysts Boss and Horvers provide an industry update and outlook on an Analyst/Industry conference call to be held on April 6 at 10:30 am.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.